Medicine and Dentistry
Systemic Lupus Erythematosus
80%
Lupus Erythematosus
40%
Rituximab
33%
Systemic Lupus Erythematosus
22%
Infection
19%
Prognostic Factor
14%
Musculoskeletal Disease
12%
Cohort Analysis
11%
Personalized Medicine
11%
Systemic Disease
11%
Clinician
11%
Hypogammaglobulinemia
11%
Rheumatic Disease
11%
Predictive Factor
11%
Mycophenolic Acid
11%
Quality Adjusted Life Year
11%
Proteomics
11%
Randomized Clinical Trial
10%
Subgroup Analysis
6%
Biological Therapy
6%
Glucocorticoid
6%
Hydroxychloroquine
6%
Disease Activity
6%
Diseases
6%
SLEDAI
5%
Treatment Development
5%
Technology Assessment
5%
Immunology and Microbiology
Systemic Lupus Erythematosus
100%
Electric Potential
55%
Lupus Erythematosus
25%
Rituximab
25%
Reduction (Chemistry)
11%
Hypogammaglobulinemia
11%
Cytokine
11%
Glucocorticoid
6%
Autoimmune Disease
6%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
77%
Systemic Lupus Erythematosus
66%
Remission
22%
Rituximab
19%
Disease Activity
16%
Infection
8%
Belimumab
8%
Disease
6%
Glucocorticoid
6%
Autoimmune Disease
6%
Mycophenolic Acid
5%